⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NRIX News
Nurix Therapeutics, Inc. Common stock
Nurix Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference
globenewswire.com
NRIX
Nurix Therapeutics Appoints Accomplished Biopharmaceutical Leader Roger Dansey, M.D., to Its Board of Directors
globenewswire.com
NRIX
Nurix Therapeutics Presents New Translational Data from First-in-Human Clinical Trial of Oral CBL-B Inhibitor NX-1607 Demonstrating Immune Activation and Tumor Microenvironment Remodeling
globenewswire.com
NRIX
Nurix Therapeutics Announces Presentations at the 67th American Society of Hematology (ASH) Annual Meeting
globenewswire.com
NRIX
Nurix Therapeutics to Participate in Upcoming Investor Conferences
globenewswire.com
NRIX
Nurix Therapeutics Announces Closing of $250.0 Million Registered Offering of Common Stock
globenewswire.com
NRIX
Precision Oncology Approaches Drive $312B Market Transformation
prnewswire.com
GTBP
NRIX
GRAL
CCCC
PFE
GTBP
NRIX
GRAL
CCCC
PFE
Nurix Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
globenewswire.com
NRIX